TrialSafety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults
Trial details
- Registry ID
- NCT05297578
- Phase
- Phase 2
PCVX
Vaxcyte, Inc.
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
6Trials in this database
13Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity sourceSafety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants
Trial details
- Registry ID
- NCT05844423
- Phase
- Phase 2
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants
Trial details
- Registry ID
- NCT06720038
- Phase
- Phase 2
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49
Trial details
- Registry ID
- NCT07284654
- Phase
- Phase 3
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age
Trial details
- Registry ID
- NCT07365826
- Phase
- Phase 3
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination
Trial details
- Registry ID
- NCT07425392
- Phase
- Phase 3
Latest recorded trial changes
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants
NCT06720038 · Vaxcyte, Inc.
Enrollment · participant count
Recorded edit− Previous value
count: 905; type: ACTUAL
+ Updated value
count: 900; type: ACTUAL
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination
NCT07425392 · Vaxcyte, Inc.
Participant count type
Recorded edit− Previous value
Estimated
+ Updated value
Actual
Enrollment · participant count
Recorded edit− Previous value
count: 720; type: ESTIMATED
+ Updated value
count: 752; type: ACTUAL
Recruitment status
Recorded edit− Previous value
Recruiting
+ Updated value
Active not recruiting
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49
NCT07284654 · Vaxcyte, Inc.
Participant count type
Recorded edit− Previous value
Estimated
+ Updated value
Actual
Enrollment · participant count
Recorded edit− Previous value
count: 4000; type: ESTIMATED
+ Updated value
count: 4049; type: ACTUAL
Recruitment status
Recorded edit− Previous value
Recruiting
+ Updated value
Active not recruiting
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age
NCT07365826 · Vaxcyte, Inc.
Participant count type
Recorded edit− Previous value
Estimated
+ Updated value
Actual
Enrollment · participant count
Recorded edit− Previous value
count: 1300; type: ESTIMATED
+ Updated value
count: 1390; type: ACTUAL
Recruitment status
Recorded edit− Previous value
Recruiting
+ Updated value
Active not recruiting
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants
NCT06720038 · Vaxcyte, Inc.
Participant count type
Recorded edit− Previous value
Estimated
+ Updated value
Actual
Enrollment · participant count
Recorded edit− Previous value
count: 900; type: ESTIMATED
+ Updated value
count: 905; type: ACTUAL
Recruitment status
Recorded edit− Previous value
Recruiting
+ Updated value
Active not recruiting